Imunon has confirmed the deprioritization of its COVID-19 vaccine program. With the company’s cash reserves falling below $5 ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen, MVA-based vaccines and solid tumor immunotherapies, today issued a statement in response to the U.S.

A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with ...

Vaccines help protect students, staff, family and the community from serious vaccine-preventable diseases,” a local public ...

Only 49% of poll respondents said they trust the Food and Drug Administration or the CDC to make sure vaccines are safe.

“Midlife women often juggle caregiving, careers, and hormonal shifts that can strain the immune system,” Boden-Albala says.

COVID-19 is surging again, indicated by rising wastewater levels and infections across many states. A new variant, Stratus (XFG), is rapidly spreading globally, characterized by a distinctive early ...

As students prepare to go back to school across Vermont and Northern New York, health care officials are reminding parents to ...

We want to know more about what these products are doing,” said Dr. Vinay Prasad in a recent FDA livestreamed presentation. The statement is made as there has been a significant policy shift in the U.

More than 120 nations have signed the new WHO Pandemic Agreement, and the U.S. is scaling its biodefense footprint through mobile biocontainment units, genomic surveillance, and expanded diagnostics.